BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia - Concepedia

Concepedia

Publication | Open Access

BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia

DOI Full Paper Access

64

Citations

7

References

1994

Year

George Gewirtz, Jack M. Gorman, Jan Volavka, Joseph Macaluso, Greta Gribkoff, Duncan P. Taylor, Richard L. Borison

Neuropsychopharmacology

Sigma Receptor LigandPsychiatryPsychotic DisorderMedicineFunctional SelectivityBmy 14802PsychopharmacologySchizophreniaNeuropharmacologyPharmacotherapyNeuroscienceBiological PsychiatryPharmacologySocial Sciences

References

	Year	Citations

Page 1

Page 1